Dermata Therapeutics, Inc (DRMA) Misses Q3 EPS by 165c
Tweet
Share
E-mailGet Alerts DRMA Hot Sheet
Join SI Premium – FREE
Dermata Therapeutics, Inc (NASDAQ: DRMA) reported Q3 EPS of ($1.65).
For earnings history and earnings-related data on Dermata Therapeutics, Inc (DRMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Fed policy stance keeps Treasury yields high, says Citadel Securities
- B.Riley Downgrades Lantheus Holdings (LNTH) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
